Cell MedX moves its manufacturing to British Columbia

May 10, 2017 – Cell MedX Corp. has announced its Canadian subsidiary has entered into a production agreement with an ISO 9001 certified manufacturing facility in Coquitlam, B.C., and selected North American suppliers for sourcing components for its eBalance Pro device.

The company explains the move will help it facilitate its planned distribution under the current registration with the U.S. Food and Drug Administration, while “ensuring lower production costs and greater control of the manufacturing and distribution process.” As well, it is intended to assist Cell MedX with setting up its standard operating procedures under ISO 13485-2016, a requirement by Health Canada to register the company’s eBalance Pro device as Class II medical device.

“Our team is very excited to continue moving ahead with our strategic plan. The new relationships that we secured with both the manufacturing facility as well as with our new suppliers is the next essential step to bring our eBalance Pro device to market,” said McEnulty, CEO.